Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53

Cancer Research

Volumn 58, Issue 24, 1998, Pages 5762-5769

  Wang, Qingjian ^a,b   Beck, William T ^a,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIPODOPHYLLOTOXIN; LUCIFERASE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; PROTEIN P53; TENIPOSIDE; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; BINDING SITE; CHO CELL; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DROSOPHILA; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; GENES, P53; HUMANS; MICE; MUTATION; PROMOTER REGIONS (GENETICS); SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032535308     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Beck, W. T. Multidrug resistance and its circumvention. Eur. J. Cancer, 26: 513-515, 1990.
2. Gros, P., Neriah, Y. B., Croop, J. M., and Housman, D. E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature (Lond.), 323: 728-731, 1986.
3. Ueda, K., Cardarelli, C., Gottesman, M. M., and Pastan, I. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA, 84: 3004-3008, 1987.
4. Endicott, J. A., and Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58: 137-171, 1989.
5. Chin, K. V., Pastan, I., and Gottesman, M. M. Function and regulation of the human multidrug resistance gene. Adv. Cancer Res., 60: 157-180, 1993.
6. Cole, S. P., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M., and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC), 258: 1650-1654, 1992.
7. Krishnamachary, N., and Center, M. S. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res., 53: 3658-3661, 1993.
8. Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P., and Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54: 357-361, 1994.
9. Zaman, G. J., Flens, M. J., van Leusden, M. R., de Haas, M., Mulder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., Broxterman, H. J., and Borst, P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA, 91: 8822-8826, 1994.
10. Kruh, G. D., Chan, A., Myers, K., Gaughan, K., Miki, T., and Aaronson, S. A. Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Res., 54: 1649-1652, 1994.
11. Iligeins, C. F. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol., 8: 67-113, 1992.
12. Cole, S. P., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54: 5902-5910, 1994.
13. Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A., Zaman, G. J., Mayer, U., Beijnen, J. H., van der Valk, M., Krimpenfort, P., and Borst, P. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med., 3: 1275-1279, 1997.
14. Lonco, A., Rappa, G., Finch, R. A., Yang, D., Flavell, R. A., and Sartorelli, A. C. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res., 57: 5238-5242, 1997.
15. Abe, T., Hasegawa, S., Taniguchi, K., Yokomizo, A., Kuwano, T., Ono, M., Mori, T., Hori, S., Kohno, K., and Kuwano, M. Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. Int. J. Cancer, 58: 860-864, 1994.
16. Burger, H., Nooter, K., Sonneveld, P., Van Wingerden, K. E., Zaman, G. J., and Stoter, G. High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia. Br. J. Haematol., 88: 348-356, 1994.
17. Loe, D. W., Deeley, R. G., and Cole, S. P. Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer, 32A: 945-957, 1996.
18. Eijdems, E. W., de Haas, M., Coco-Martin, J. M., Ottenheim, C. P., Zaman, G. J., Dauwerse, H. G., Breuning, M. H., Twentyman, P. R., Borst, P., and Baas, F. Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP amplicon. Int. J. Cancer, 60: 676-684, 1995.
19. Burger, H., Nooter, K., Zaman, G. J., Sonneveld, P., Van Wingerden, K. E., Oostrum, R. G., and Stoter, G. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia (Baltimore), 8: 990-997, 1994.
20. Slovak, M. L., Ho, J. P., Bhardwaj, G., Kurz, E. U., Deeley, R. G., and Cole, S. P. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Res., 53: 3221-3225, 1993.
21. Slapak, C. A., Fracasso, P. M., Martell, R. L., Toppmeyer, D. L., Lecerf, J. M., and Levy, S. B. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Cancer Res., 54: 5607-5613, 1994.
22. Vogelstein, B., and Kinzler, K. W. p53 function and dysfunction. Cell, 70: 523-526, 1992.
23. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
24. Zambetti, G. P., and Levine, A. J. A comparison of the biological activities of wild-type and mutant p53. FASEB J., 7: 855-865, 1993.